RIYADH, Nov 7 (Reuters) - British drugmaker GlaxoSmithKline is currently Saudi Arabia's sole supplier of a vaccine for the H1N1 flu virus, the health ministry spokesman said on Saturday.
'For the moment, the only vaccine that has been authorised is the GlaxoSmithKline vaccine Pandemrix,' health ministry spokesman Khaled Mirghalani told Reuters.
'We will in the future get vaccines from other clients, from other companies as soon as they get approved by the SFDA (Saudi Food and Drug Authority),' he said.
(Reporting by Nael Shyoukhi, writing by Raissa Kasolowsky; Editing by Sanjeev Miglani) Keywords: FLU SAUDI/GLAXO (raissa.kasolowsky@thomsonreuters.com; Reuters Messaging: raissa.kasolowsky.reuters.com@reuters.net; +971 4 391 8031) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
'For the moment, the only vaccine that has been authorised is the GlaxoSmithKline vaccine Pandemrix,' health ministry spokesman Khaled Mirghalani told Reuters.
'We will in the future get vaccines from other clients, from other companies as soon as they get approved by the SFDA (Saudi Food and Drug Authority),' he said.
(Reporting by Nael Shyoukhi, writing by Raissa Kasolowsky; Editing by Sanjeev Miglani) Keywords: FLU SAUDI/GLAXO (raissa.kasolowsky@thomsonreuters.com; Reuters Messaging: raissa.kasolowsky.reuters.com@reuters.net; +971 4 391 8031) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.